Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.

Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.

10.1158/1078-0432.CCR-20-1727

Saved in:

Bibliographic Details
Main Authors:	Chong, Wan Qin, Lim, Chwee Ming, Sinha, Arvind Kumar, Tan, Chee Seng, Chan, Gloria Hui Jia, Huang, Yiqing, Barr Kumarakulasinghe, Nesaretnam, Sundar, Raghav, Jeyasekharan, Anand D, Loh, Woei Shyang, Tay, Joshua K., Yadav, Kritika, Wang, Lingzhi, Wong, Andrea L., Kong, Li Ren, Soo, Ross Andrew, Lau, Jieying Amelia, Soon, Yu Yang, Goh, Robby Miguel, Ho, Francis Cho Hao, Chong, Siew Meng, Lee, Soo-Chin, Loh, Kwok Seng, Tai, Bee Choo, Lim, Yaw Chyn, Goh, Boon Cher
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	American Association for Cancer Research (AACR) 2020
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175619
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Pharmacology of Gemcitabine in the Asian Population
by: WANG LINGZHI
Published: (2010)

Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014)

Does saturable formation of gemcitabine triphosphate occur in patients?
by: Tham, L.-S., et al.
Published: (2014)

Antiangiogenic therapy in malignant glioma: Promise and challenge
by: Sith Sathornsumetee, et al.
Published: (2018)

Developing antiangiogenic peptide drugs for angiogenesis-related diseases
by: Sulochana, K.N., et al.
Published: (2014)

Decorin derived antiangiogenic peptide LRR5 inhibits endothelial cell migration by interfering with VEGF-stimulated NO release
by: Fan, H., et al.
Published: (2011)

Decorin derived antiangiogenic peptide LRR5 inhibits endothelial cell migration by interfering with VEGF-stimulated NO release
by: Fan, H., et al.
Published: (2014)

Development of antiangiogenic peptides from human decorin and characterization of their modes of action
by: FAN HUAPENG
Published: (2019)

Synthesis of Thiourea Derivatives from M-Methoxycinnamic Acid as Antiangiogenic Candidate
by: Juni Ekowati, et al.
Published: (2019)

Synthesis of Thiourea Derivatives from M-Methoxycinnamic Acid As Antiangiogenic Candidate.
by: Juni Ekowati, -, et al.
Published: (2019)

Comparison Between Gemcitabine-Carboplatin and Combination of Gemcitabine-Carboplatin and Celecoxib in Urothelial Carcinoma Cell Apoptosis
by: Widya Sakti Pratama, et al.
Published: (2019)

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, Vachiranee, et al.
Published: (2018)

Synthesis and evaluation of 1-(substituted)-3-prop-2-ynylureas as antiangiogenic agents
by: Kingkan Sanphanya, et al.
Published: (2018)

Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients
by: Soo, R.A., et al.
Published: (2011)

Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effect
by: Wang, L.-Z., et al.
Published: (2014)

Antiangiogenic effects of VH02, a novel urea derivative: In vitro and in vivo studies
by: Suwadee Phowichit, et al.
Published: (2018)

Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-naïve patient: A comprehensive review of the literature
by: Kununya Pimolbutr, et al.
Published: (2019)

Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
by: Hermawan, Adam, et al.
Published: (2022)

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients
by: Wong, A.L.-A., et al.
Published: (2014)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
by: Bandla, Aishwarya, et al.
Published: (2021)

The Differences of Apoptosis Effects Between Combination of Meloxicam with Gemcitabine-Carboplatin Chemotherapy Compared to Gemcitabine-Carboplatin Chemotherapy Alone in Urothelial Carcinoma Culture Cells
by: Ananta Cahyo Nugroho, et al.
Published: (2019)

Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018)

PERBEDAAN EFEK APOPTOSIS PEMBERIAN KOMBINASI MELOKSIKAM DAN KEMOTERAPI GEMCITABINE CARBOPLATIN DIBANDINGKAN KEMOTERAPI GEMCITABINE CARBOPLATIN PADA SEL KULTUR KARSINOMA UROTHELIAL
by: Ananta Cahyo Nugroho, NIM01131896305
Published: (2018)

Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
by: Graepler, F., et al.
Published: (2014)

Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI
by: Rajendran, R, et al.
Published: (2020)

Factors influencing venous pain in patients with cancer receiving gemcitabine
by: Rasarudee Sriwisai, et al.
Published: (2019)

Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014)

Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells
by: Koh, V, et al.
Published: (2020)

SYSTEMS LEVEL ANALYSIS OF CELLULAR RESPONSES TO GEMCITABINE IN B-CELL LYMPHOMA
by: CHAN KAIXUAN JUSTIN
Published: (2022)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, V, et al.
Published: (2020)

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group study
by: Soo, R.A., et al.
Published: (2014)

Gemcitabine after bone marrow transplantation for refractory juvenile granulosa cell tumor
by: Andrzej P. Kudelka, et al.
Published: (2018)

Small wind energy harvesting using piezoelectric material
by: Chong, Jieying
Published: (2014)

Different treatment efficacies and side effects of cytotoxicchemotherapy
by: Wang Lingzhi, et al.
Published: (2020)

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix
by: Alfonso Dueñas-González, et al.
Published: (2018)

Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
by: Nunghathai Sawasdee, et al.
Published: (2020)

Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
by: Nunghathai Sawasdee, et al.
Published: (2020)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2011)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer
by: Soo, R.A., et al.
Published: (2014)